The monkeypox virus was first isolated in Copenhagen in 1958. It causes similar lesions to smallpox and should be distinguished from other pathogens such as Mycobacterium leprae, Varicella zoster virus and cowpox, as these viruses can also cause similar types of lesions. Smallpox was eradicated by vaccination in the early 1980s, so the new generation is not vaccinated; therefore, there is a risk that there is no protection against smallpox and related viruses. In Africa, this virus breaks out due to close contact between people. Such a viral infection can be contained by better hygienic conditions and the use of disinfectants, but in many African countries the hygienic conditions are so poor and poverty is probably another reason why the monkeypox virus cannot be controlled. The virus is spreading in other countries, such as the USA, where more than 30,000 positive cases have been reported with many deaths. This virus is also mutating and to control the spread of this virus, people need to be tested as the 1b clone is spreading in many countries. To control the spread of the virus, it is therefore necessary to differentiate the strains. Therefore, we present a protocol to distinguish between the monkeypox virus (all clades) and the 1b clade.
This test can be used on different isolated samples from different lesions like skin, plasma, serum, oral swabs, genital lesion samples.